{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T17:24:36Z","timestamp":1794936276902,"version":"4.9.1"},"reference-count":47,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"37","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1097\/md.0000000000008034","type":"journal-article","created":{"date-parts":[[2017,9,12]],"date-time":"2017-09-12T20:23:08Z","timestamp":1505247788000},"page":"e8034","source":"Crossref","is-referenced-by-count":139,"title":["Comparison of fertility-sparing treatments in patients with early endometrial cancer and atypical complex hyperplasia"],"prefix":"10.1097","volume":"96","author":[{"given":"Jing","family":"Wei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiyuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Limin","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanli","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-44-20210309","doi-asserted-by":"crossref","first-page":"87","DOI":"10.3322\/caac.21262","article-title":"Global cancer statistics, 2012","volume":"65","author":"Torre","year":"2015","journal-title":"CA Cancer J Clin"},{"key":"R2-44-20210309","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/caac.21332","article-title":"Cancer statistics, 2012","volume":"66","author":"Siegel","year":"2016","journal-title":"CA Cancer J Clin"},{"key":"R3-44-20210309","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/modpathol.3880051","article-title":"Theories of endometrial carcinogenesis: a multidisciplinary approach","volume":"13","author":"Sherman","year":"2000","journal-title":"Mod Pathol"},{"key":"R4-44-20210309","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1177\/1933719114522517","article-title":"Complex atypical hyperplasia of the endometrium: differences in outcome following conservative management of pre- and postmenopausal women","volume":"21","author":"Brownfoot","year":"2014","journal-title":"Reprod Sci"},{"key":"R5-44-20210309","doi-asserted-by":"crossref","first-page":"2214","DOI":"10.1148\/rg.2016150254","article-title":"Role of imaging in fertility-sparing treatment of gynecologic malignancies","volume":"36","author":"Butterfield","year":"2016","journal-title":"Radiographics"},{"key":"R6-44-20210309","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.ajog.2011.01.025","article-title":"Fertility preserving options in patients with gynecologic malignancies","volume":"205","author":"Eskander","year":"2011","journal-title":"Am J Obstet Gynecol"},{"key":"R7-44-20210309","doi-asserted-by":"crossref","first-page":"S32","DOI":"10.1016\/j.ygyno.2009.04.010","article-title":"Indications and teaching of fertility preservation in the surgical management of gynecologic malignancies: European perspective","volume":"114","author":"Leblanc","year":"2009","journal-title":"Gynecol Oncol"},{"key":"R8-44-20210309","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.ygyno.2012.01.003","article-title":"Oncologic and Reproductive outcomes with progestin therapy in women with endometrial hyperplasia and grade 1 adenocarcinoma: a systematic review","volume":"125","author":"Gunderson","year":"2012","journal-title":"Gynecol Oncol"},{"key":"R10-44-20210309","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.ygyno.2014.06.003","article-title":"Endometrial cancer: a review and current management strategies: part II","volume":"134","author":"Burke","year":"2014","journal-title":"Gynecol Oncol"},{"key":"R11-44-20210309","first-page":"1755","article-title":"Progestin therapy for endometrial cancer: the potential of fourth-generation progestin (review)","volume":"40","author":"Banno","year":"2012","journal-title":"Int J Oncol"},{"key":"R12-44-20210309","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1093\/molehr\/gap042","article-title":"Dienogest, a synthetic progestin, inhibits the proliferation of immortalized human endometrialepithelial cells with suppression of cyclin D1 gene expression","volume":"15","author":"Shimizu","year":"2009","journal-title":"Mol Hum Reprod"},{"key":"R13-44-20210309","doi-asserted-by":"crossref","first-page":"W65","DOI":"10.7326\/0003-4819-151-4-200908180-00136","article-title":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration","volume":"151","author":"Liberati","year":"2009","journal-title":"Ann Int Med"},{"key":"R15-44-20210309","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s12958-015-0136-7","article-title":"Factors affecting pregnancy outcomes in young women treated with fertility-preserving therapy for well-differentiated endometrial cancer or atypical endometrial hyperplasia","volume":"14","author":"Inoue","year":"2016","journal-title":"Reprod Biol Endocrinol"},{"key":"R16-44-20210309","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1093\/annonc\/mdv539","article-title":"Phase II study of medroxyprogesterone acetate plus metformin as a fertility-sparing treatment for atypical endometrial hyperplasia and endometrial cancer","volume":"27","author":"Mitsuhashi","year":"2016","journal-title":"Ann Oncol"},{"key":"R17-44-20210309","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1097\/IGC.0000000000000629","article-title":"Exploring morphologic and molecular aspects of endometrial cancer under progesterone treatment in the context of fertility preservation","volume":"26","author":"van Gent","year":"2016","journal-title":"Int J Gynecol Cancer"},{"key":"R18-44-20210309","first-page":"133","article-title":"Cyclic versus continuous medroxyprogesterone acetate for treatment of endometrial hyperplasia without atypia: a 2-year observational study","volume":"292","author":"Emarh","year":"2015","journal-title":"Arch Gynecol Obs"},{"key":"R19-44-20210309","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.ijgo.2015.06.046","article-title":"Oncologic and reproductive outcomes after fertility-sparing management with oral progestin for women with complex endometrial hyperplasia and endometrial cancer","volume":"132","author":"Chen","year":"2016","journal-title":"Int J Gynecol Obstet"},{"key":"R20-44-20210309","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s00404-014-3417-z","article-title":"Efficacies and pregnant outcomes of fertility-sparing treatment with medroxyprogesterone acetate for endometrioid adenocarcinoma and complex atypical hyperplasia: our experience and a review of the literature","volume":"291","author":"Ohyagi-Hara","year":"2015","journal-title":"Arch Gynecol Obstet"},{"key":"R21-44-20210309","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1016\/j.ejca.2012.09.017","article-title":"Long-term oncologic outcomes after fertility-sparing management using oral progestin for young women with endometrial cancer (KGOG 2002)","volume":"49","author":"Park","year":"2013","journal-title":"Eur J Cancer"},{"key":"R22-44-20210309","first-page":"651","article-title":"Fertility sparing treatment in young patients with early endometrial adenocarcinoma","volume":"29","author":"Shobeiri","year":"2013","journal-title":"Pakistan J Med Sci"},{"key":"R23-44-20210309","first-page":"1037","article-title":"Progestin treatment of atypical hyperplasia and well-differentiated adenocarcinoma of the endometrium to preserve fertility","volume":"32","author":"Koskas","year":"2012","journal-title":"Anticancer Res"},{"key":"R24-44-20210309","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1007\/s00404-011-1959-x","article-title":"Effectiveness of high-dose progestin and long-term outcomes in young women with early-stage, well-differentiated endometrioid adenocarcinoma of uterine endometrium","volume":"285","author":"Park","year":"2012","journal-title":"Arch Gynecol Obstet"},{"key":"R25-44-20210309","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1111\/IGC.0b013e3181aae1fb","article-title":"Conservative treatment with progestin and pregnancy outcomes in endometrial cancer","volume":"19","author":"Hahn","year":"2009","journal-title":"Int J Gynecol Cancer"},{"key":"R26-44-20210309","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1111\/j.1471-0528.2008.02024.x","article-title":"Fertility-sparing treatment in young women with endometrial cancer or atypical complex hyperplasia: a prospective single-institution experience of 21 cases","volume":"116","author":"Signorelli","year":"2009","journal-title":"BJOG"},{"key":"R27-44-20210309","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1016\/j.fertnstert.2009.06.013","article-title":"Fertility-preserving treatment in young women with well-differentiated endometrial carcinoma and severe atypical hyperplasia of endometrium","volume":"92","author":"Yu","year":"2009","journal-title":"Fertil Steril"},{"key":"R28-44-20210309","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.canlet.2006.06.013","article-title":"Combined phospho-Akt and PTEN expressions associated with post-treatment hysterectomy after conservative progestin therapy in complex atypical hyperplasia and stage Ia, G1 adenocarcinoma of the endometrium","volume":"248","author":"Minaguchi","year":"2007","journal-title":"Cancer Lett"},{"key":"R29-44-20210309","doi-asserted-by":"crossref","first-page":"2798","DOI":"10.1200\/JCO.2006.08.8344","article-title":"Multicenter phase II study of fertility-sparing treatment with medroxyprogesterone acetate for endometrial carcinoma and atypical hyperplasia in young women","volume":"25","author":"Ushijima","year":"2007","journal-title":"J Clin Oncol"},{"key":"R30-44-20210309","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1093\/humrep\/dem088","article-title":"Fertility-preserving treatment with progestin, and pathological criteria to predict responses, in young women with endometrial cancer","volume":"22","author":"Yamazawa","year":"2007","journal-title":"Hum Reprod"},{"key":"R31-44-20210309","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1111\/j.1471-0528.2004.00398.x","article-title":"Outcome of fertility-preserving treatment in young women with endometrial carcinomas","volume":"112","author":"Niwa","year":"2005","journal-title":"BJOG"},{"key":"R32-44-20210309","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1136\/ijgc-00009577-200507000-00012","article-title":"Clinicopathologic study of uterine endometrial carcinoma in young women aged 40 years and younger","volume":"15","author":"Ota","year":"2005","journal-title":"Int J Gynecol Cancer"},{"key":"R33-44-20210309","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0304-3835(01)00462-1","article-title":"Conservative therapy for adenocarcinoma and atypical endometrial hyperplasia of the endometrium in young women: central pathologic review and treatment outcome","volume":"167","author":"Kaku","year":"2001","journal-title":"Cancer Lett"},{"key":"R34-44-20210309","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1002\/(SICI)1097-0142(19970115)79:2<320::AID-CNCR15>3.0.CO;2-2","article-title":"Progestin alone as primary treatment of endometrial carcinoma in premenopausal women. Report of seven cases and review of the literature","volume":"79","author":"Kim","year":"1997","journal-title":"Cancer"},{"key":"R35-44-20210309","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1097\/IGC.0000000000000467","article-title":"Fertility-sparing treatment of early endometrial cancer and complex atypical hyperplasia in young women of childbearing potential","volume":"25","author":"Pronin","year":"2015","journal-title":"Int J Gynecol Cancer"},{"key":"R36-44-20210309","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1093\/annonc\/mdq463","article-title":"Progestin intrauterine device and GnRH analogue for uterus-sparing treatment of endometrial precancers and well-differentiated early endometrial carcinoma in young women","volume":"22","author":"Minig","year":"2011","journal-title":"Ann Oncol"},{"key":"R37-44-20210309","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.ajog.2013.06.031","article-title":"Combined medroxyprogesterone acetatelevonorgestrel-intrauterine system treatment in young women with early-stage endometrial cancer.","volume":"209","author":"Kim","year":"2013","journal-title":"Am J Obstet Gynecol"},{"key":"R38-44-20210309","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1111\/ajo.12142","article-title":"Long-term outcomes after progestogen treatment for early endometrial cancer","volume":"53","author":"Cade","year":"2013","journal-title":"Aust N Z J Obstet Gynaecol"},{"key":"R39-44-20210309","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1111\/j.1471-0528.2010.02552.x","article-title":"Progestogen treatment options for early endometrial cancer","volume":"117","author":"Cade","year":"2010","journal-title":"BJOG"},{"key":"R40-44-20210309","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1097\/IGC.0b013e31820003de","article-title":"Prolonged conservative treatment of endometrial cancer patients","volume":"21","author":"Perri","year":"2011","journal-title":"Int J Gynecol Cancer"},{"key":"R41-44-20210309","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1097\/AOG.0b013e31828d6186","article-title":"Systemic and local hormone therapy for endometrial hyperplasia and early adenocarcinoma","volume":"121","author":"Hubbs","year":"2013","journal-title":"Obstet Gynecol"},{"key":"R42-44-20210309","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.ygyno.2010.10.004","article-title":"Conservative treatment of early endometrial cancer: preliminary results of a pilot study","volume":"120","author":"Laurelli","year":"2011","journal-title":"Gynecol Oncol"},{"key":"R43-44-20210309","doi-asserted-by":"crossref","first-page":"266e1","DOI":"10.1016\/j.ajog.2012.08.011","article-title":"Regression, relapse, and live birth rates with fertility-sparing therapy for endometrial cancer and atypical complex endometrial hyperplasia: a systematic review and metaanalysis","volume":"207","author":"Gallos","year":"2012","journal-title":"Am J Obstet Gynecol"},{"key":"R44-44-20210309","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.fertnstert.2013.11.028","article-title":"Prognostic factors of oncologic and reproductive outcomes in fertility-sparing management of endometrial atypical hyperplasia and adenocarcinoma: Systematic review and meta-analysis","volume":"101","author":"Koskas","year":"2014","journal-title":"Fertil Steril"},{"key":"R45-44-20210309","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1089\/gyn.2012.0007","article-title":"Safe fertility-preserving management in endometrial cancer: is it feasible? Review of the literature","volume":"28","author":"Carneiro","year":"2012","journal-title":"J Gynecol Surg"},{"key":"R46-44-20210309","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1007\/s00384-017-2782-z","article-title":"The effect of metformin on the recurrence of colorectal adenoma in diabetic patients with previous colorectal adenoma","volume":"32","author":"Han","year":"2017","journal-title":"Int J Colorectal Dis"},{"key":"R47-44-20210309","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1097\/IGC.0000000000000603","article-title":"Use of metformin in obese women with type i endometrial cancer is associated with a reduced incidence of cancer recurrence","volume":"26","author":"Hall","year":"2016","journal-title":"Int J Gynecol Cancer"},{"key":"R48-44-20210309","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.ygyno.2013.11.021","article-title":"Metformin is associated with improved survival in endometrial cancer","volume":"132","author":"Ko","year":"2014","journal-title":"Gynecol Oncol"},{"key":"R49-44-20210309","first-page":"1","article-title":"Regret around fertility choices is decreased with pre-treatment counseling in gynecologic cancer patients","volume":"11","author":"Chan","year":"2016","journal-title":"J Cancer Surviv"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000008034","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T02:32:57Z","timestamp":1620959577000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00005792-201709150-00044"}},"subtitle":["A meta-analysis and systematic review"],"short-title":[],"issued":{"date-parts":[[2017,9]]},"references-count":47,"journal-issue":{"issue":"37","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000008034","relation":{},"ISSN":["0025-7974"],"issn-type":[{"value":"0025-7974","type":"print"}],"subject":[],"published":{"date-parts":[[2017,9]]}}}